These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 15587503)
21. The role of FXR in disorders of bile acid homeostasis. Eloranta JJ; Kullak-Ublick GA Physiology (Bethesda); 2008 Oct; 23():286-95. PubMed ID: 18927204 [TBL] [Abstract][Full Text] [Related]
22. Nuclear receptors as potential drug targets in osteoarthritis. Sun MM; Beier F; Ratneswaran A Curr Opin Pharmacol; 2018 Jun; 40():81-86. PubMed ID: 29626714 [TBL] [Abstract][Full Text] [Related]
23. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. Giri S; Rattan R; Singh AK; Singh I J Immunol; 2004 Oct; 173(8):5196-208. PubMed ID: 15470065 [TBL] [Abstract][Full Text] [Related]
24. Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy. Patel HJ; Belvisi MG; Bishop-Bailey D; Yacoub MH; Mitchell JA J Immunol; 2003 Mar; 170(5):2663-9. PubMed ID: 12594295 [TBL] [Abstract][Full Text] [Related]
33. Regulation of the CYP3A4 gene by hydrocortisone and xenobiotics: role of the glucocorticoid and pregnane X receptors. El-Sankary W; Plant NJ; Gibson GG; Moore DJ Drug Metab Dispos; 2000 May; 28(5):493-6. PubMed ID: 10772626 [TBL] [Abstract][Full Text] [Related]
34. Nuclear receptors, bile-acid detoxification, and cholestasis. Chen J; Raymond K Lancet; 2006 Feb; 367(9509):454-6. PubMed ID: 16473109 [No Abstract] [Full Text] [Related]
36. Effects of tryptophan related compounds on nuclear regulatory control. Possible role in the eosinophilia-myalgia syndrome. Sidransky H; Verney E; Latham P; Schwartz A Adv Exp Med Biol; 1996; 398():343-50. PubMed ID: 8906287 [No Abstract] [Full Text] [Related]
37. COX-2 and cancer: a new approach to an old problem. Bakhle YS Br J Pharmacol; 2001 Nov; 134(6):1137-50. PubMed ID: 11704632 [No Abstract] [Full Text] [Related]
38. Synthesis and biological activity of adenophostin derivatives as IP3 receptor ligands. Shuto S; Mochizuki T; Abe H; Kondo Y; Matsuda A Nucleic Acids Res Suppl; 2002; (2):23-4. PubMed ID: 12903086 [TBL] [Abstract][Full Text] [Related]
39. Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease. Fuchs CD; Traussnigg SA; Trauner M Semin Liver Dis; 2016 Feb; 36(1):69-86. PubMed ID: 26870934 [TBL] [Abstract][Full Text] [Related]
40. Superior nuclear receptor selectivity and therapeutic index of methylprednisolone aceponate versus mometasone furoate. Mirshahpanah P; Döcke WD; Merbold U; Asadullah K; Röse L; Schäcke H; Zollner TM Exp Dermatol; 2007 Sep; 16(9):753-61. PubMed ID: 17697148 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]